Yoga therapy as an adjunct to conventional management of systemic sclerosis: A case series

Systemic sclerosis (SSc) is an autoimmune disorder leading to significant disability and loss of Quality of Life (QoL). Yoga has become popular in recent times for its potential therapeutic benefits. Since there are no scientific reports on the use of Yoga for SSc, we present two female cases (aged...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Apar Avinash Saoji, Pranab Das, Naorem Subhadra Devi
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Lifestyle Scleroderma Inflammation Autoimmunity Mind-body medicine Miscellaneous systems and treatments RZ409.7-999
Acceso en línea:	https://doaj.org/article/327ed334c66f4835baa81c9e02a15799
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:327ed334c66f4835baa81c9e02a15799
record_format	dspace
spelling	oai:doaj.org-article:327ed334c66f4835baa81c9e02a157992021-12-02T04:59:20ZYoga therapy as an adjunct to conventional management of systemic sclerosis: A case series0975-947610.1016/j.jaim.2021.06.013https://doaj.org/article/327ed334c66f4835baa81c9e02a157992021-10-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0975947621001212https://doaj.org/toc/0975-9476Systemic sclerosis (SSc) is an autoimmune disorder leading to significant disability and loss of Quality of Life (QoL). Yoga has become popular in recent times for its potential therapeutic benefits. Since there are no scientific reports on the use of Yoga for SSc, we present two female cases (aged 49 and 29 respectively) of limited SSc (duration of illness 4 and 3 years respectively) who underwent Yoga therapy as an adjunct to conventional management in a residential setting for a period of five and four weeks, respectively. During their stay, they underwent a specifically designed Yoga module. After their discharge, they were followed-up for four weeks, during which they were asked to continue practicing Yoga for 1 h every day. Both of them reported a reduction in pain, stiffness, symptom scores, and improved QoL on discharge and at the follow-up compared to the values on admission. Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP), as biomarkers of inflammation, reduced on the discharge when compared to the baseline. No adverse events were noted during the stay and the follow-up. Thus, the present case series indicate a possible beneficial role of Yoga as an adjunct therapy to conventional management of SSc. Further studies in the area are warranted to ascertain the efficacy of Yoga for SSc.Apar Avinash SaojiPranab DasNaorem Subhadra DeviElsevierarticleLifestyleSclerodermaInflammationAutoimmunityMind-body medicineMiscellaneous systems and treatmentsRZ409.7-999ENJournal of Ayurveda and Integrative Medicine, Vol 12, Iss 4, Pp 705-709 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Lifestyle Scleroderma Inflammation Autoimmunity Mind-body medicine Miscellaneous systems and treatments RZ409.7-999
spellingShingle	Lifestyle Scleroderma Inflammation Autoimmunity Mind-body medicine Miscellaneous systems and treatments RZ409.7-999 Apar Avinash Saoji Pranab Das Naorem Subhadra Devi Yoga therapy as an adjunct to conventional management of systemic sclerosis: A case series
description	Systemic sclerosis (SSc) is an autoimmune disorder leading to significant disability and loss of Quality of Life (QoL). Yoga has become popular in recent times for its potential therapeutic benefits. Since there are no scientific reports on the use of Yoga for SSc, we present two female cases (aged 49 and 29 respectively) of limited SSc (duration of illness 4 and 3 years respectively) who underwent Yoga therapy as an adjunct to conventional management in a residential setting for a period of five and four weeks, respectively. During their stay, they underwent a specifically designed Yoga module. After their discharge, they were followed-up for four weeks, during which they were asked to continue practicing Yoga for 1 h every day. Both of them reported a reduction in pain, stiffness, symptom scores, and improved QoL on discharge and at the follow-up compared to the values on admission. Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP), as biomarkers of inflammation, reduced on the discharge when compared to the baseline. No adverse events were noted during the stay and the follow-up. Thus, the present case series indicate a possible beneficial role of Yoga as an adjunct therapy to conventional management of SSc. Further studies in the area are warranted to ascertain the efficacy of Yoga for SSc.
format	article
author	Apar Avinash Saoji Pranab Das Naorem Subhadra Devi
author_facet	Apar Avinash Saoji Pranab Das Naorem Subhadra Devi
author_sort	Apar Avinash Saoji
title	Yoga therapy as an adjunct to conventional management of systemic sclerosis: A case series
title_short	Yoga therapy as an adjunct to conventional management of systemic sclerosis: A case series
title_full	Yoga therapy as an adjunct to conventional management of systemic sclerosis: A case series
title_fullStr	Yoga therapy as an adjunct to conventional management of systemic sclerosis: A case series
title_full_unstemmed	Yoga therapy as an adjunct to conventional management of systemic sclerosis: A case series
title_sort	yoga therapy as an adjunct to conventional management of systemic sclerosis: a case series
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/327ed334c66f4835baa81c9e02a15799
work_keys_str_mv	AT aparavinashsaoji yogatherapyasanadjuncttoconventionalmanagementofsystemicsclerosisacaseseries AT pranabdas yogatherapyasanadjuncttoconventionalmanagementofsystemicsclerosisacaseseries AT naoremsubhadradevi yogatherapyasanadjuncttoconventionalmanagementofsystemicsclerosisacaseseries
_version_	1718400880495034368

Yoga therapy as an adjunct to conventional management of systemic sclerosis: A case series

Ejemplares similares